Literature DB >> 2784140

IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells.

C P Chiu1, F Lee.   

Abstract

IL-6 has multiple biologic activities in different cell systems including both the ability to support cell proliferation and to induce differentiation. We reported previously the isolation and functional expression of a mouse IL-6 (mIL-6) cDNA clone derived from bone marrow stromal cells. In this paper, we show that mIL-6 is a potent inducer of terminal macrophage differentiation for a mouse myeloid leukemic cell line, M1. Addition of mIL-6 to cultures of M1 cells rapidly inhibits their proliferation and induces phagocytic activity and morphologic changes characteristic of mature macrophages. These phenotypic changes are accompanied at the molecular level by a decrease in proto-oncogene c-myc mRNA accumulation and increases in Fc gamma R, proto-oncogenes c-fos and c-fms (CSF-1R) mRNA expression. Furthermore, IL-6 enhances the expression of Fc gamma R and c-fms in differentiation-responsive D+, but not unresponsive D- sublines of mouse myelomonocytic leukemic WEHI-3B cells. Together with our previous observation that IL-6 stimulates colony formation by normal myeloid progenitors, these results strongly suggest an important regulatory role for IL-6 in myeloid cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784140

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

2.  Granulocyte-macrophage colony-stimulating factor elevates invariant chain expression in immature myelomonocytic cell lines.

Authors:  I Klagge; U Kopp; N Koch
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  The genes for leukemia inhibitory factor and interleukin-6 are expressed in mouse blastocysts prior to the onset of hemopoiesis.

Authors:  R Murray; F Lee; C P Chiu
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

4.  Differentiation of the rat myelomonocytic leukemia cell line c-WRT-7 by in vitro culture with the rat bone marrow preadipocyte cell line REC A16.

Authors:  T Tanaka; S Okamura; S Yasumoto; N Takeichi; H Kobayashi; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.

Authors:  A F Voronova; F Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

6.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.

Authors:  T M Rose; A G Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Theiler's virus-induced intrinsic apoptosis in M1-D macrophages is Bax mediated and restricts virus infectivity: a mechanism for persistence of a cytolytic virus.

Authors:  Kyung-No Son; Robert P Becker; Patricia Kallio; Howard L Lipton
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

8.  Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo.

Authors:  G J Dougherty; J D Thacker; R S Lavey; A Belldegrun; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

Review 9.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

10.  Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Authors:  Tieying Hou; Brian C Tieu; Sutapa Ray; Adrian Recinos Iii; Ruwen Cui; Ronald G Tilton; Allan R Brasier
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.